179 related articles for article (PubMed ID: 29155984)
1. Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes.
Klingenberg R; Aghlmandi S; Liebetrau C; Räber L; Gencer B; Nanchen D; Carballo D; Akhmedov A; Montecucco F; Zoller S; Brokopp C; Heg D; Jüni P; Marti Soler H; Marques-Vidal PM; Vollenweider P; Dörr O; Rodondi N; Mach F; Windecker S; Landmesser U; von Eckardstein A; Hamm CW; Matter CM; Lüscher TF
Eur Heart J; 2017 Dec; 38(47):3493-3502. PubMed ID: 29155984
[TBL] [Abstract][Full Text] [Related]
2. Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.
Klingenberg R; Aghlmandi S; Räber L; Akhmedov A; Gencer B; Carballo D; Nanchen D; Bucher HC; Rodondi N; Mach F; Windecker S; Landmesser U; von Eckardstein A; Hamm CW; Lüscher TF; Matter CM
J Am Heart Assoc; 2021 Oct; 10(20):e020488. PubMed ID: 34622666
[TBL] [Abstract][Full Text] [Related]
3. Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.
Reiser H; Klingenberg R; Hof D; Cooksley-Decasper S; Fuchs N; Akhmedov A; Zoller S; Marques-Vidal P; Marti Soler H; Heg D; Landmesser U; Rodondi N; Mach F; Windecker S; Vollenweider P; Matter CM; Lüscher TF; von Eckardstein A; Gawinecka J
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1872-9. PubMed ID: 26069234
[TBL] [Abstract][Full Text] [Related]
4. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Planer D; Mehran R; Ohman EM; White HD; Newman JD; Xu K; Stone GW
Circ Cardiovasc Interv; 2014 Jun; 7(3):285-93. PubMed ID: 24847016
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin S Levels and Survival Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
Stamatelopoulos K; Mueller-Hennessen M; Georgiopoulos G; Lopez-Ayala P; Sachse M; Vlachogiannis NI; Sopova K; Delialis D; Bonini F; Patras R; Ciliberti G; Vafaie M; Biener M; Boeddinghaus J; Nestelberger T; Koechlin L; Tual-Chalot S; Kanakakis I; Gatsiou A; Katus H; Spyridopoulos I; Mueller C; Giannitsis E; Stellos K
J Am Coll Cardiol; 2022 Sep; 80(10):998-1010. PubMed ID: 36049808
[TBL] [Abstract][Full Text] [Related]
8. hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial.
Ferencik M; Liu T; Mayrhofer T; Puchner SB; Lu MT; Maurovich-Horvat P; Pope JH; Truong QA; Udelson JE; Peacock WF; White CS; Woodard PK; Fleg JL; Nagurney JT; Januzzi JL; Hoffmann U
JACC Cardiovasc Imaging; 2015 Nov; 8(11):1272-1281. PubMed ID: 26476506
[TBL] [Abstract][Full Text] [Related]
9. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
[TBL] [Abstract][Full Text] [Related]
10. Anaemia to predict outcome in patients with acute coronary syndromes.
Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
[TBL] [Abstract][Full Text] [Related]
11. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum cysteine-rich protein 61 levels in patients with coronary artery disease.
Deng J; Qian X; Li J; Li Y; Li Y; Luo Y
Biomark Med; 2018 Apr; 12(4):329-339. PubMed ID: 29345157
[TBL] [Abstract][Full Text] [Related]
13. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
Taşolar H; Çetin M; Ballı M; Bayramoğlu A; Otlu YÖ; Türkmen S; Aktürk E
Anatol J Cardiol; 2016 Oct; 16(10):742-748. PubMed ID: 27025198
[TBL] [Abstract][Full Text] [Related]
14. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).
Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM
JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881
[TBL] [Abstract][Full Text] [Related]
15. Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the Netherlands.
Oemrawsingh RM; Akkerhuis KM; Umans VA; Kietselaer B; Schotborgh C; Ronner E; Lenderink T; Liem A; Haitsma D; van der Harst P; Asselbergs FW; Maas A; Oude Ophuis AJ; Ilmer B; Dijkgraaf R; de Winter RJ; The SH; Wardeh AJ; Hermans W; Cramer E; van Schaik RH; Hoefer IE; Doevendans PA; Simoons ML; Boersma E
BMJ Open; 2016 Dec; 6(12):e012929. PubMed ID: 28011810
[TBL] [Abstract][Full Text] [Related]
16. Approach to non-ST-segment elevation acute coronary syndrome in the emergency department: risk stratification and treatment strategies.
Lefebvre CW; Hoekstra J
Hosp Pract (1995); 2010 Apr; 38(2):40-9. PubMed ID: 20469612
[TBL] [Abstract][Full Text] [Related]
17. Association of Cyr61-cysteine-rich protein 61 and short-term mortality in patients with acute heart failure and coronary heart disease.
Liu C; Cao Y; He X; Zhang C; Liu J; Zhang L; Wu D; Zhuang X; Xue R; Huang H; Jiang J; Dong B; Sun Y; Dong Y; Zhao J
Biomark Med; 2019 Dec; 13(18):1589-1597. PubMed ID: 31660756
[No Abstract] [Full Text] [Related]
18. PRediction of acute coronary syndrome in acute ischemic StrokE (PRAISE) - protocol of a prospective, multicenter trial with central reading and predefined endpoints.
Nolte CH; von Rennenberg R; Litmeier S; Scheitz JF; Leistner DM; Blankenberg S; Dichgans M; Katus H; Petzold GC; Pieske B; Regitz-Zagrosek V; Wegscheider K; Zeiher AM; Landmesser U; Endres M
BMC Neurol; 2020 Aug; 20(1):318. PubMed ID: 32854663
[TBL] [Abstract][Full Text] [Related]
19. Elevated Serum Angiopoietin-like Protein 2 in Patients with Acute Coronary Syndrome.
Wang Z; Zheng H; Chen H; Lin X; Chen J; Wang L; Bao W; Lin X; Huang M; Luo Z
Arch Med Res; 2015 May; 46(4):257-64. PubMed ID: 25999029
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
